Tag: nephrology
Obinutuzumab Outperforms Tacrolimus for Primary Membranous Nephropathy
Landmark NEJM trial shows obinutuzumab achieves 60% higher remission rates than tacrolimus in primary membranous nephropathy. The study enrolled 929…
Kidney Drug Finerenone Shows Promise for Non-Diabetic Chronic Kidney Disease
New clinical trial data show finerenone reduces kidney disease progression by 23% in non-diabetic patients. The drug could benefit millions…
Finerenone Shows Cardiovascular Benefits in Non-Diabetic Chronic Kidney Disease Patients
Finerenone significantly reduces cardiovascular events by 14% in non-diabetic chronic kidney disease patients, according to landmark NEJM trial. The drug…
Submit Your Paper to GMJ
No APC until January 2027.